Using BrainScope One in Urgent Care Centers Shows Potential 75% Reduction in Head Injury Referrals to Emergency Departments

BrainScope
May 7, 2018

Brain­Scope One Pro­vides Objec­tive, Action­able Infor­ma­tion for Assess­ment of Mildly Pre­sent­ing Head Injured Patients in Urgent Care Cen­ters, Emer­gency Depart­ments, and Other Settings

 BETHESDA, MD. MAY 7, 2018 – Brain­Scope announced today the release of a white paper authored by Urgent Care physi­cians which demon­strated that the FDA-​​cleared Brain­Scope One had the poten­tial to reduce unnec­es­sary Emer­gency Depart­ment refer­rals by up to seventy-​​five per­cent.  Brain­Scope One offers a rapid (within min­utes) assess­ment of the full spec­trum of trau­matic brain injury (TBI), includ­ing con­cus­sion, using dig­i­tal elec­troen­cephalog­ra­phy (EEG) and other modal­i­ties, facil­i­tat­ing accu­rate and timely decision-​​making for first respon­ders, clin­i­cians, and other health prac­ti­tion­ers at the point of care wher­ever an injury occurs.

Close to 5 mil­lion peo­ple who expe­ri­ence a TBI seek care and treat­ment at hos­pi­tal Emer­gency Depart­ments (EDs) in the U.S. each year, where over 80% of these patients are eval­u­ated using a com­puted tomog­ra­phy (CT) scan of the head to detect brain tis­sue dam­age, or intracra­nial lesions, that may require treat­ment.  Over 90% of these CT scans are found to be neg­a­tive, unnec­es­sar­ily expos­ing patients to radi­a­tion, long wait times, and high costs.

Urgent Care Cen­ters have become an increas­ingly pop­u­lar alter­na­tive to the ED for patients who are expe­ri­enc­ing ill­ness and injuries – such as mild head injuries includ­ing con­cus­sion – that don’t nec­es­sar­ily rise to an emer­gency level.  Uti­liz­ing Brain­Scope One, health­care pro­fes­sion­als at Urgent Care Cen­ters have the poten­tial to sig­nif­i­cantly impact the triage, assess­ment, and care of mildly pre­sent­ing head injured patients.

Using data for the first 196 Urgent Care Cen­ter patients entered in the Brain­Scope One Reg­istry, physi­cians prac­tic­ing at Bet­terMed Urgent Care (VA) and Ban­ner Health (AZ, CA, CO, NE, NV, and WY) com­pared refer­ral for CT scans with and with­out inte­gra­tion of the Brain­Scope One assess­ment. The ini­tial results assume that under stan­dard clin­i­cal prac­tice – with­out the use of Brain­Scope One – all patients would have been referred to the ED for CT scans. The study focused on mildly pre­sent­ing patients (aver­age GCS of 14.9), ages 18–45, rep­re­sent­ing approx­i­mately 75% of the patients in the Reg­istry.  Within this pop­u­la­tion, the authors demon­strated that the inte­gra­tion of Brain­Scope One in the Urgent Care Cen­ter can aid in sig­nif­i­cant diver­sion from ED refer­rals of up to 75%.

Alvaro Zebal­los, MD, Chief Growth Offi­cer at Bet­terMed Urgent Care stated, “We have found that uti­liz­ing Brain­Scope One has helped us to bet­ter man­age head injured patients, decreas­ing ED vis­its and CT uti­liza­tion, while help­ing us diag­nose patients who will need treat­ment for con­cus­sions, improv­ing their outcomes.”

The sig­nif­i­cant diver­sion demon­strated in this white paper not only helps Urgent Care providers bet­ter man­age and diag­nose their head injured patients, it can also relieve ED over­crowd­ing and patient wait times, elim­i­nate unnec­es­sary CT scans and radi­a­tion expo­sure, and reduce costs incurred by the patient and insur­ers, result­ing in an over­all ben­e­fit to patients and the broader health­care system.

In addi­tion, last week Brain­Scope announced the release of a white paper authored by physi­cians at Wash­ing­ton Uni­ver­sity Barnes Jew­ish Med­ical Cen­ter in St. Louis, which demon­strated that the FDA-​​cleared Brain­Scope One had the poten­tial to reduce the use of unnec­es­sary head CT scans by one-​​third in a hos­pi­tal Emer­gency Depart­ment setting.

The white paper enti­tled “Poten­tial to Reduce Emer­gency Depart­ment Refer­rals From Urgent Care Cen­ters By Up to 75% for Mildly Pre­sent­ing Head Injured Patients” can be found here:  http://​brain​scope​.com/​m​e​d​i​a​/​2​0​1​8​/​5​/​6​/​u​r​g​e​n​t​c​a​r​e​-​e​d​-​d​i​v​e​r​s​i​o​n​-​w​h​i​t​e​-​p​a​per.

The white paper enti­tled “Poten­tial Sig­nif­i­cant Reduc­tion in Unnec­es­sary CT Scans in Emer­gency Depart­ments Using an FDA Cleared Med­ical Device for Brain Injury Assess­ment” can be found here:  http://​brain​scope​.com/​m​e​d​i​a​/​2​0​1​8​/​4​/​2​9​/​w​a​s​h​i​n​g​t​o​n​-​u​n​i​v​e​r​s​i​t​y​-​e​m​e​r​g​e​n​c​y​-​d​e​p​a​r​t​m​e​n​t​-​w​h​i​t​e​-​p​a​per.

For more infor­ma­tion about the Brain­Scope tech­nol­ogy, visit www​.brain​scope​.com/​p​r​o​d​u​cts.

About Brain­Scope

Brain­Scope Com­pany, Inc. (“Brain­Scope”) is a med­ical neu­rotech­nol­ogy com­pany that is devel­op­ing a new gen­er­a­tion of hand­held non-​​invasive devices designed to aid med­ical pro­fes­sion­als in rapidly and objec­tively assess­ing var­i­ous neu­ro­log­i­cal con­di­tions, begin­ning with trau­matic brain injury (TBI), includ­ing con­cus­sion. The company’s first prod­uct intro­duced in 2017, Brain­Scope One (FDA cleared as Ahead 300), uses EEG-​​based tech­nol­ogy that is non-​​invasive for mildly pre­sent­ing patients 18–85 years old and within 3 days after head injury and is not a replace­ment to CT scan. BrainScope’s tech­nol­ogy plat­form inte­grates data­bases of thou­sands of brain­wave record­ings with advanced dig­i­tal sig­nal pro­cess­ing, sophis­ti­cated algo­rithms, minia­tur­ized hard­ware and dis­pos­able head­set sen­sors, which are all cov­ered by an exten­sive intel­lec­tual prop­erty port­fo­lio of over 100 issued and pend­ing patents. Brain­Scope has received four FDA clear­ances and ISO 13485:2003 Cer­ti­fi­ca­tion. Brain­Scope has part­nered with the U.S. Depart­ment of Defense for the devel­op­ment of its TBI assess­ment tech­nol­ogy, and was named both an orig­i­nal recip­i­ent and final awardee of the GE-​​NFL Head Health Chal­lenge I. For more infor­ma­tion, please visit www​.brain​scope​.com.